Dilated cardiomyopathy
Conditions
Interventions
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Left ventricular end-diastolic diameter (LVEDd)>5.0cm (female), LVEDd>5.5cm (male); LVEF<45%, left ventricular short-axis shortening rate (LVFS) < 25%; 2. NYHA cardiac function class II-III; 3. Aged 18-75 years, gender is not limited, the patient signed the informed consent; 4. No other symptomatic traditional Chinese medicine preparations have been taken in the past 2 weeks.
Exclusion criteria
Exclusion criteria: 1. Viral myocarditis, rheumatic cardiomyopathy, ischemic heart disease, diabetic heart disease, valvular heart disease and other structural heart disease with clear etiology; 2. Patients with severe liver and kidney damage, cancer and mental illness; 3. Pregnant and lactating women; 4. Patients with severe heart, liver, kidney, blood, and nervous system diseases; 5. Patients with non-cooperation or poor compliance due to other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| End-diastolic diameter;Left ventricular ejection fraction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Left ventricular fractional shortening;NT-proBNP;6-Minute Walking Distance;TCM score;Safety indicators; | — |
Countries
China
Contacts
Public ContactLi Jun
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed